SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001169245-23-000019
Filing Date
2023-05-16
Accepted
2023-05-16 16:23:08
Documents
5
Period of Report
2023-03-31
Effectiveness Date
2023-05-16

Document Format Files

Seq Description Document Type Size
1 NT 10-Q phasebio-nt10xqq12023.htm NT 10-Q 11971
2 GRAPHIC phasebio-nt10xqq12023001.jpg GRAPHIC 107789
3 GRAPHIC phasebio-nt10xqq12023002.jpg GRAPHIC 170148
4 GRAPHIC phasebio-nt10xqq12023003.jpg GRAPHIC 286697
5 GRAPHIC phasebio-nt10xqq12023004.jpg GRAPHIC 107961
  Complete submission text file 0001169245-23-000019.txt   939949
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 23927856
SIC: 2834 Pharmaceutical Preparations